Application Area
This article explores the challenges posed by RNase contamination and the solutions that can be employed to mitigate these risks. RNase contamination | Ribonuclease inhibitors | RNase-free equipment
David Seifert
August 13, 2024
Application Area
RNase contamination can lead to the degradation of RNA, thereby compromising the efficacy of RNA-based drugs. Types of RNase | RNase and DNase | Role of DEPC
David Seifert
August 12, 2024
Application Area
Ensuring that cell and gene therapy products are shipped at cold temperatures with robust controls is even more important for cell & gene therapies than it is for more traditional biopharmaceutical products.
Michael Mühlegger
July 8, 2024
Application Area
In biosimilar production, fluid management takes on an overarching role, as it is encountered at several manufacturing steps. This is all the more reason to deal with efficiency in fluid management – which we will do in this article.
Brian Moloney
May 14, 2024
Application Area
The manufacturing process of biosimilars is a complex endeavor, accompanied by several challenges. We will discuss some of the biggest hurdles in this article, along with solutions to overcome them.
Brian Moloney
May 14, 2024
Application Area
There are several parameters to be considered in the attempt to maximize efficiency in biomanufacturing. In this article, we will discuss different areas that have an impact on process efficiency, including ways to improve them.
Michael Mühlegger
May 13, 2024
Application Area
The development process of biosimilars slightly differs from the one of their reference biologics. In this article, we will discuss each phase in detail.
Michael Eder
May 13, 2024
Application Area
As biologics have become a central pillar in today’s healthcare sector, their manufacturing process increasingly draws attention. In this article, we will discuss the process step by step, including challenges and possible ways to overcome them.
Michael Eder
May 13, 2024
Application Area
Establishing both efficient and safe manufacturing processes for biosimilars requires planning, expertise, and state-of-the-art equipment. In this article, we will shed light on different steps in the manufacturing process and discuss ways to improve them.
Application Area
Freezing and thawing are essential steps in the cold chain management of biosimilars. With several methods eligible, we have chosen some prominent ones, explaining their advantages, limitations, and our preferred choices.
Alexander Fuchs
May 8, 2024
Application Area
Over the years, several biosimilars have been approved as alternatives for often more costly biologics. We have listed them, along with the product they refer to.
Michael Mühlegger
May 8, 2024
Application Area
Biosimilars are a popular alternative to reference biologics they resemble. But what has led to this popularity, and what’s to know about their manufacturing? Find out in this article!